OpenBench is radically improving the economics of drug discovery by pioneering a success-driven partnership approach to early small molecule discovery. In defiance of the prevailing (and broken) ‘fee-for-service’ paradigm in hit discovery, we screen billions of molecules and our biotech partners only pay for what works: potent, novel, and developable Hits and leads.
Our partners are biotech companies and academic researchers working on first-in-class and best-in-class small molecule therapeutics across a range of indications including cancer and rare disease.
We are always eager to work with exceptionally talented people. If you are interested in joining us, please send a copy of your CV and a cover letter to email@example.com.